Colony formation and cellular viability assays delineated the proliferative boost imparted by PDIA3, with PD-1 antibody treatment effectively mitigating these effects, thereby underscoring PDIA3’s crucial role in regulating both cell proliferation and the immune signaling interface within the colorectal cancer milieu. This evidence concerns the gene PDCD1 and colorectal cancer.